麻豆传媒

Lymphoma Canada is pleased to announce that it is accepting applications for 2022 research funding until March 31.

These funds are intended to support small, well-defined research studies that have the potential to effect improvements in healthcare, health systems, and/or health outcomes as they pertain to malignant lymphoproliferative diseases.

Proposed research studies may address any of the following broad areas of research, including but not limited to:

• patient-reported outcomes;
• comparative clinical effectiveness;
• pharmaco-economics; or
• health care utilization.

Further information and a link to apply can be .

Deadlines

Internal: March 24, 2022 at 4:30pm. Contact is susan.haydt@dal.ca.
Click here for guidance on internal deadlines and submission processes.

Funder: March 31, 2022. Contact is聽info@lymphoma.ca